FDA

FDA allows criminal drug company to market generic Lipitor drug containing tiny shards of glass

Wednesday, December 05, 2012 by: Ethan A. Huff, staff writer
Tags: heart drugs, glass shards, FDA

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
The five biggest lies about Ebola being pushed by government and mass media
Why does the CDC own a patent on Ebola 'invention?'
White House admits staging fake vaccination operation to gather DNA from the public
Ultraviolet light robot kills Ebola in two minutes; why doesn't every hospital have one of these?
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
Tetanus vaccines found spiked with sterilization chemical to carry out race-based genocide against Africans
Russia taking McDonald's to court, threatens countrywide shutdown
Oregon man serving prison sentence for collecting rainwater on his own property
The best way to help your body protect itself against Ebola (or any virus or bacteria)
Global warming data FAKED by government to fit climate change fictions
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Healthy 12-year-old girl dies shortly after receiving HPV vaccine
Ebola outbreak may already be uncontrollable; Monsanto invests in Ebola treatment drug company as pandemic spreads
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Ben & Jerry's switches to non-GMO, Fair Trade ice cream ingredients
W.H.O. contradicts CDC, admits Ebola can spread via coughing, sneezing and by touching contaminated surfaces

Delicious
(NaturalNews) For the second time in fewer than four months, India-based drug giant Ranbaxy Pharmaceuticals Inc. has issued a formal recall on its drug atorvastatin calcium, which is a generic version of the popular cholesterol drug Lipitor. According to reports, the company, which has been the subject of U.S. Food and Drug Administration (FDA) investigations since 2006 because of fraud, publicly released more than 40 lots of the tainted drug, which this time was found to contain tiny pieces of glass.

The recall affects all 10, 20, and 40-milligram doses of the drug produced by Ranbaxy, according to an announcement posted on the company's website. The vast majority of the tainted lots are reportedly composed of 90-pill bottles in each of these sizes, while at least three of the recalled lots include 500-pill bottles. Ranbaxy claims its 80-milligram doses of the drug are not affected by the recall.

"Ranbaxy is proactively recalling the drug product lots out of an abundance of caution," wrote company spokesman Chuck Caprariello in a generic statement about the recall, which was reportedly issued to the public a full two weeks after Ranbaxy first notified pharmacies. "This recall is being conducted with the full knowledge of the U.S. FDA," he added, refusing to offer any further comments.

Patients who take generic atorvastatin calcium for cholesterol in the affected doses are being urged to contact their pharmacies immediately to inquire about whether or not their medication is tainted. Since neither the FDA nor Ranbaxy know just how many bottles of medicine may contain tiny shards of glass, it is best for patients to exercise caution and avoid taking generic Lipitor pills from bottles that may be included as part of the recall.

FDA allowed Ranbaxy to sell generic Lipitor in U.S. with full knowledge of company's illegal activities

As reported by the New York Daily News (NYDN), the FDA first launched an investigation into Ranbaxy back in 2006 after learning about the company's questionable manufacturing processes and what appeared to be illicit behavior. The FDA eventually found that Ranbaxy was not only failing to test the shelf life of its products, which was putting patients in danger, but had also lied about its drug safety tests, which prompted the agency to issue sanctions against Ranbaxy.

In 2008, the FDA took further action against Ranbaxy by blocking the import of nearly 30 of the company's drugs from India into the U.S. The U.S. Department of Justice (DOJ) also demanded at the time that Ranbaxy surrender internal documents revealing what it alleged to be blatantly fraudulent behavior. According to reports, Ranbaxy had repeatedly lied to regulators about the ingredients and formulations of several of its drugs.

The situation worsened in 2009 when the FDA finally decided to block all new applications from Ranbaxy to sell drugs in the U.S. But on November 30, 2011, the day Lipitor was to lose its patent protection, the FDA suddenly, and without a reason, reversed its position and allowed Ranbaxy to begin producing a generic version of the drug and shipping it into the U.S.

This means the FDA knowingly and willingly put Americans in danger by apparently caving to pressures from Ranbaxy, India's largest drug company, to remove the sanctions and once again allow imports of dangerous generic drugs into the U.S. It remains to be seen whether or not anyone at the FDA will be held criminally responsible for this blatant disregard for public safety.

Sources for this article include:

http://www.nydailynews.com

http://news.yahoo.com

http://www.industryweek.com

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.